Login to Your Account



Other News To Note


Tuesday, May 31, 2011
• Archer Pharmaceuticals Inc., of Sarasota, Fla., said an international research consortium led by researchers at Trinity College Dublin said they were recommended for funding for a large-scale European Phase III trial of Nilvadipine in Alzheimer's disease. The grant is awarded by the European Commission Seventh Framework Programme.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription